You're contacting media contact of this press release

Title: Nava Health Announces New Precision-Driven Longevity Protocols Following Landmark 2026 Menopause Study

United States, 12th Mar 2026 — New clinical findings released in 2026 are reshaping the conversation around hormone health and aging. As growing research highlights the benefits of Bioidentical Hormone Replacement Therapy (BHRT), Nava Health is announcing the expansion of its precision-driven longevity protocols designed to help men and women restore hormonal balance and improve overall health outcomes.Historically, hormone therapy has faced skepticism due to earlier studies that evaluated synthetic hormone treatments. However, recent data and improved clinical practices are helping to distinguish bioidentical hormone therapy from older hormone replacement models. These updated insights confirm that properly prescribed and medically monitored BHRT can be a safe and effective option for individuals experiencing hormone imbalances associated with menopause, perimenopause, and andropause.According to health experts, hormone imbalance can significantly affect daily life. Symptoms such as fatigue, brain fog, sleep disturbances, mood swings, decreased libido, and unexplained weight gain are often linked to hormonal shifts that occur naturally with age. Bioidentical hormone therapy addresses these changes by restoring optimal levels of estrogen, progesterone, and testosterone using plant-derived compounds that are chemically identical to the hormones naturally produced by the human body.At Nava Health, BHRT is delivered through a comprehensive, data-driven approach that emphasizes early detection and personalized care. The clinic integrates advanced diagnostic testing, clinical evaluation, and continuous monitoring to develop customized hormone optimization plans tailored to each patient’s biology and long-term health goals.The clinic’s longevity program includes mor...

This press release is issued by King Newswire